ArticleFrontiers in public health2026
Epidemiology and treatment outcomes of TB-HIV co-infection in a rural South African setting: an exploratory analysis of retreatment and contextual factors.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculosis-HIV (TB-HIV) co-infection remains a major public health challenge in South Africa, particularly in rural settings where clinical, socioeconomic, and health-system factors may influence treatment outcomes. This study examined the epidemiological characteristics of TB-HIV co-infection and factors associated with tuberculosis treatment outcomes in a rural Eastern Cape cohort. Methods: A retrospective cohort study was conducted using routinely collected programmatic data from 422 adult tuberculosis patients treated between 2018 and 2022. Baseline demographic and clinical characteristics were summarized descriptively. Associations between patient characteristics and treatment success were evaluated using univariable and multivariable logistic regression analyses. An exploratory Random Forest (RF) model was additionally applied to assess predictive performance and identify variables contributing to outcome classification. Model performance was evaluated using Precision-Recall curves and Average Precision (AP). Results: The prevalence of TB-HIV co-infection was 57.8%. Treatment success rates were similar between TB-HIV co-infected and TB-only patients, and HIV status was not independently associated with treatment success in adjusted analyses. Previous TB treatment was associated with lower treatment success in univariable analysis (OR = 0.48; 95% CI: 0.29-0.78), although this association did not remain statistically significant after adjustment. Mortality was 6.6% among TB-HIV co-infected patients and 10.7% among TB-only patients, with no statistically significant difference between groups. The RF model demonstrated higher predictive performance (AP = 0.907) than logistic regression (AP = 0.810). Feature importance analysis identified socioeconomic characteristics, including education, income source, and employment status, as important contributors to model performance. Conclusion: TB-HIV co-infection was highly prevalent in this rural cohort; however, treatment success and mortality outcomes were comparable between TB-HIV co-infected and TB-only patients. While HIV status was not independently associated with treatment outcomes, the absence of detailed HIV-related clinical information limits the interpretation of the underlying mechanisms. The exploratory machine-learning analysis suggests that socioeconomic factors may contribute to outcome prediction, highlighting the importance of considering broader contextual influences alongside clinical characteristics when designing interventions to improve tuberculosis treatment outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.